[1]刘辉,古力米热木·买买提江,李万富,等.儿童亲体肝移植11例回顾性分析[J].临床小儿外科杂志,2023,22(12):1124-1129.[doi:10.3760/cma.j.cn101785-202306008-006]
　Liu Hui,Gulimiremu Maimaitijiang,Li Wanfu,et al.Experiences of pro-liver transplantation in children:a report of 11 cases[J].Journal of Clinical Pediatric Surgery,2023,22(12):1124-1129.[doi:10.3760/cma.j.cn101785-202306008-006]
点击复制

儿童亲体肝移植11例回顾性分析

《临床小儿外科杂志》[ISSN:1671-6353/CN:43-1380/R] 卷: 第22卷 期数: 2023年12 页码: 1124-1129 栏目: 专题·儿童肝母细胞瘤的诊治 出版日期: 2023-12-28
Title:
Experiences of pro-liver transplantation in children:a report of 11 cases
作者:
刘辉1;  古力米热木·买买提江1;  李万富1;  沈中阳2;  高伟2;  董冲2;  孙超2;  阿尔新·哈布丁1;  樊珈榕1
1 新疆医科大学第一附属医院小儿普外科, 乌鲁木齐 830054;
2 天津市第一中心医院儿童器官移植科, 天津 300192
Author(s):
Liu Hui1;  Gulimiremu Maimaitijiang1;  Li Wanfu1;  Shen Zhongyang2;  Gao Wei2;  Dong Chong2;  Sun Chao2;  Aerxin Habuding1;  Fan Jiarong1
1 Department of General Pediatric Surgery, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, China;
2 Department of Pediatric Organ Transplantation, First Central Municipal Hospital, Tianjin 300192, China
关键词:
肝移植/方法; 活体供者/分类; 活体肝移植; 免疫抑制法; 治疗结果; 儿童
Keywords:
Liver Transplantation/MT; Living Donors/CL; Living Donor Liver Transplantation; Immunosuppression; Treatment Outcome; Child
DOI:
10.3760/cma.j.cn101785-202306008-006
摘要:
目的 总结儿童亲体肝移植的临床疗效与经验。方法 回顾性分析2021年9月至2023年2月新疆医科大学第一附属医院实施的11例亲体肝移植患儿临床资料,原发病包括:胆道闭锁2例,门静脉海绵样变性2例,肝豆状核变性3例,酪氨酸血症Ⅰ型1例,先天性肝纤维化2例,布-加综合征1例。肝移植术后均予抗感染、保肝、利胆、抗凝及免疫抑制治疗;8例采取他克莫司+吗替麦考酚酯加甲基强的松龙三联免疫抑制治疗,3例采取他克莫司加甲基强的松龙二联免疫抑制治疗。结果 11例手术时间(11.85±1.85)h,移植物与受体重量比(graft-to-recipient weight ratio,GRWR)为(2.20±2.03)%,冷缺血时间为(75.91±20.87)min,热缺血时间为(2.63±2.30)min,无肝期时间为(60.55±18.86)min,术中出血量为(770.91±541.12)mL。11例中行胆道端端吻合术4例,胆肠吻合术7例。术后无一例血管及胆道相关并发症,但出现血小板减少1例、肺部感染1例、淋巴漏2例、癫痫发作1例、高血压伴烦躁不安1例,均经对症治疗后痊愈出院。供体无一例术后并发症。结论 亲体肝移植术是治疗儿童终末期肝病及部分肝脏遗传代谢性疾病的有效手段,应严格把握不同原发疾病的肝移植手术指征,并结合个体化围手术期管理,以提高手术成功率,减少并发症。
Abstract:
Objective To summarize the clinical efficacies and outcomes of pediatric living donor liver transplantation (LDLT). Methods From September 2021 to February 2023,retrospective analysis was performed for the relevant clinical data of 11 children undergoing LDLT at First Affiliated Hospital of Xinjiang Medical University.Primary diseases included biliary atresia (n=2),portal vein cavernous degeneration (n=2),hepatolenticular degeneration (n=3),tyrosinemia type Ⅰ (n=1),congenital liver fibrosis (n=2) and Budd-Chiari syndrome (n=1).Postoperative interventions included anti-infection,liver protection,bile promotion,anticoagulation and immunosuppression.The immunosuppressive protocols were a triple regimen of tacrolimus,mycophenolate mofetil and methylprednisolone (n=8) and a dual regimen of tacrolimus and methylprednisolone (n=3). Results Mean operative duration was (11.85±1.85) h,mean graft-to-recipient weight ratio (GRWR) (2.20±2.03) %,mean cold ischemic time (75.91±20.87) min,mean warm ischemic time (2.63±2.30) min,mean anhepatic period (60.55±18.86) min and mean intraoperative volume of hemorrhagic loss (770.91±541.12) mL.End-to-end biliary anastomosis (n=4) and bile-intestinal anastomosis (n=7) were performed.There were no vascular or biliary postoperative complications.However,there were thrombocytopenia (n=1),lung infection (n=1),lymphatic leakage (n=2),seizure (n=1) and hypertension with irritability (n=1).All of them were cured and discharged after symptomatic measures.No postoperative complications occurred in donors.Conclusions LDLT is an effective treatment for end-stage liver disease and some genetically metabolic liver diseases in children.Indications for LDLT should be strictly tailored for different primary diseases.And perioperative managements are individualized for optimizing long-term survivals and quality-of-life.

参考文献/References:

[1] 陆晔峰,夏强,邱必军,等.儿童肝移植术后长期生存的相关问题分析[J].临床肝胆病杂志,2019,35(11):2396-2401.DOI:10.3969/j.issn.1001-5256.2019.11.004. Lu YF,Xia Q,Qiu BJ,et al.Analyses of related issues in long-term survival in children after liver transplantation[J].J Clin Hepatol,2019,35(11):2396-2401.DOI:10.3969/j.issn.1001-5256.2019.11.004.
[2] Pham YH,Miloh T.Liver transplantation in children[J].Clin Liver Dis,2018,22(4):807-821.DOI:10.1016/j.cld.2018.06.004.
[3] 中华医学会器官移植学分会.中国肝移植术操作规范(2019版)[J].临床肝胆病杂志,2020,36(1):36-39.DOI:10.3969/j.issn.1001-5256.2020.01.006. Chinese Society of Organ Transplantation,Chinese Medical Association:Operative Standards for Liver Transplantation in China (Edition 2019)[J].J Clin Hepatol,2020,36(1):36-39.DOI:10.3969/j.issn.1001-5256.2020.01.006.
[4] 李姗霓,王凯,马楠,等.Kasai手术对胆道闭锁儿童行活体肝移植术的影响[J].天津医药,2016,4(7):817-820.DOI:10.11958/20160239. Li SN,Wang K,Ma N,et al.Effects of Kasai surgery on living donor liver transplantation for biliary atresia in children[J].Tianjin Med J,2016,44(7):817-820.DOI:10.11958/20160239.
[5] 朱志军,孙丽莹,魏林,等.肝移植治疗小儿胆道闭锁130例报道[J].中华小儿外科杂志,2014,35(4):259-264.DOI:10.3760/cma.j.issn.0253-3006.2014.04.006. Zhu ZJ,Sun LY,Wei L,et al.Liver transplantation for biliary atresia in children:a report of 130 cases[J].Chin J Pediatr Surg,2014,35(4):259-264.DOI:10.3760/cma.j.issn.0253-3006.2014.04.006.
[6] 赵东,夏强.小儿肝移植的现状与展望[J].肝胆外科杂志,2017,25(4):244-247.DOI:10.3969/j.issn.1006-4761.2017.04.003. Zhao D,Xia Q.Current status and prospects of pediatric liver transplantation[J].J Hepatobiliary Surg,2017,25(4):244-247.DOI:10.3969/j.issn.1006-4761.2017.04.003.
[7] Rela M,Kaliamoorthy I,Reddy MS.Current status of auxiliary partial orthotopic liver transplantation for acute liver failure[J].Liver Transpl,2016,22(9):1265-1274.DOI:10.1002/lt.24509.
[8] Mazariegos G,Shneider B,Burton B,et al.Liver transplantation for pediatric metabolic disease[J].Mol Genet Metab,2014,111(4):418-427.DOI:10.1016/j.ymgme.2014.01.006.
[9] 中华医学会器官移植学分会,中国医师协会器官移植医师分会.中国儿童肝移植临床诊疗指南(2015版)[J].中华移植杂志(电子版),2016,10(1):2-11.DOI:10.3877/cma.j.issn.1674-3903.2016.01.002. Branch of Organ Transplantation,Chinese Medical Association; Branch of Organ Transplantation Physicians,Chinese Medical Doctor Association:.Clinical Diagnostic and Therapeutic Guidelines for Liver Transplantation in Children in China (Edition 2015)[J].Chin J Transplant (Electron Ed),2016,10(1):2-11.DOI:10.3877/cma.j.issn.1674-3903.2016.01.002.
[10] 韩环立,张明满,郭春宝,等.胆道闭锁肝移植术后早期肝动脉血栓的诊断及处理[J].临床小儿外科杂志,2017,16(2):138-141,150.DOI:10.3969/j.issn.1671-6353.2017.02.008. Han HL,Zhang MM,Guo CB,et al.Diagnoses and treatments of early-stage hepatic artery thrombosis after liver transplantation for biliary atresia[J].J Clin Ped Sur,2017,16(2):138-141,150.DOI:10.3969/j.issn.1671-6353.2017.02.008.
[11] SuperinaR,ShneiderB,EmreS,et al.Surgical guidelines for the management of extra-hepatic portal vein obstruction[J].Pediatr Transplant,2006,10(8):908-913.DOI:10.1111/j.1399-3046.2006.00598.x.
[12] 孙蕊,李龙.儿童门静脉海绵样变性的外科手术治疗研究进展[J].临床小儿外科杂志,2020,19(12):1145-1151.DOI:10.3969/j.issn.1671-6353.2020.12.016. Sun R,Li L.Research surgical advances for cavernous transformation of portal vein in children[J].J Clin Ped Sur,2020,19(12):1145-1151.DOI:10.3969/j.issn.1671-6353.2020.12.016.
[13] 高伟.先天性代谢紊乱肝移植的适应证[J].实用器官移植电子杂志,2018,6(6):419-420,418.DOI:10.3969/j.issn.2095-5332.2018.06.001. Gao W.Indications for liver transplantation with congenital metabolic disorders[J].Prac J Organ Transplant (Electronic Version),2018,6(6):419-420,418.DOI:10.3969/j.issn.2095-5332.2018.06.001.
[14] Kerr DN,Harrison CV,Sherlock S,et al.Congenital hepatic fibrosis[J].Q J Med,1961,30:91-117.
[15] Vogel I,Ott P,Lildballe D,et al.Isolated congenital hepatic fibrosis associated with TMEM67 mutations:report of a new genotype-phenotype relationship[J].Clin Case Rep,2017,5(7):1098-1102.DOI:10.1002/ccr3.981.
[16] 刘源,夏强,张建军,等.活体肝移植治疗Ⅰ型酪氨酸血症的疗效[J].中华小儿外科杂志,2017,38(8):563-566.DOI:10.3760/cma.j.issn.0253-3006.2017.08.002. Liu Y,Xia Q,Zhang JJ,et al.Efficacies of living donor liver transplantation for hereditary tyrosinemia type Ⅰ[J].Chin J Pediatr Surg,2017,38(8):563-566.DOI:10.3760/cma.j.issn.0253-3006.2017.08.002.
[17] Scott CR.The genetic tyrosinemias[J].Am J Med Genet C Semin Med Genet,2006,142C(2):121-126.DOI:10.1002/ajmg.c.30092.

相似文献/References:

[1]周峻 王政 李龙 侯文英 谢华伟 崔龙 王文晓. 临时性门腔静脉架桥联合流出道改良重建在部分供肝肝移植中应用的实验研究[J].临床小儿外科杂志,2011,10(03):179.
　[J].Journal of Clinical Pediatric Surgery,2011,10(12):179.
[2]单禹华,顾松,徐敏,等.小儿肝移植术后肠梗阻病因鉴别及预后分析[J].临床小儿外科杂志,2021,20(06):576.[doi:10.12260/lcxewkzz.2021.06.013]
　Shan Yuhua,Gu Song,Xu Min,et al.Differentiation and prognosis of intestinal obstruction after pediatric liver transplantation[J].Journal of Clinical Pediatric Surgery,2021,20(12):576.[doi:10.12260/lcxewkzz.2021.06.013]
[3]夏强,朱欣烨.儿童肝移植发展现状及展望[J].临床小儿外科杂志,2022,21(05):401.[doi:10.3760/cma.j.cn101785-202202028-001]
　Xia Qiang,Zhu Xinye.Current development and future outlook of pediatric liver transplantation[J].Journal of Clinical Pediatric Surgery,2022,21(12):401.[doi:10.3760/cma.j.cn101785-202202028-001]
[4]许陈诚,姜大朋.儿童肾脏移植中需要关注的供体因素[J].临床小儿外科杂志,2022,21(05):410.[doi:10.3760/cma.j.cn101785-202111027-003]
　Xu Chencheng,Jiang Dapeng.Donor factors for kidney transplantation in children[J].Journal of Clinical Pediatric Surgery,2022,21(12):410.[doi:10.3760/cma.j.cn101785-202111027-003]
[5]高伟.扩大儿童肝脏移植供体来源途径[J].临床小儿外科杂志,2022,21(05):405.[doi:10.3760/cma.j.cn101785-202203014-002]
　Gao Wei.Expanding the sources of donor pool for pediatric liver transplantation[J].Journal of Clinical Pediatric Surgery,2022,21(12):405.[doi:10.3760/cma.j.cn101785-202203014-002]
[6]袁远宏,张慧,肖政辉,等.血浆置换治疗儿童亲属活体肝移植术后抗体介导排斥反应的疗效分析[J].临床小儿外科杂志,2022,21(05):425.[doi:10.3760/cma.j.cn101785-202202012-006]
　Yuan Yuanhong,Zhang Hui,Xiao Zhenghui,et al.Therapeutic effect of plasma exchange on antibody mediated rejection after living relative donor liver transplantation in children[J].Journal of Clinical Pediatric Surgery,2022,21(12):425.[doi:10.3760/cma.j.cn101785-202202012-006]

备注/Memo

收稿日期:2023-6-4。
基金项目:国家自然科学基金面上项目(82170672)
通讯作者:李万富,Email:13699982169@163.com

更新日期/Last Update: 1900-01-01